This appendix deals with problems of dosimetry for radionuclides decaying (a) by electron capture and (b) with the emission of relatively low energy {3 particles, which are of interest in the general context of this report and also raise certain questions on radiobiological effectiveness.
Introduction
The use of radionuclides which decay by electron capture and/or internal conversion, such as 51 Cr, 67Ga, 75Se, 8 5 Sr, 99Tcm, 125 1, has been expanding rapidly in diagnostic nuclear medicine and radiobiological research. The radionuclide 125 1 has been extensively studied in various biological systems and has also been tried therapeutically in thyrotoxic patients instead of 131 1. The low energy {3-particle emitters, such as 3H, 14 C and 35 S constitute another group of labels useful in biological studies.
The special importance of inner-shell vacancies, produced by irradiation or radioactive decay, was pointed out by Platzman (1952) . The electronic rearrangements triggered by an inner shell vacancy consist of a cascade of low-energy Auger electrons and fluorescent x rays. The resulting multiply charged atom may lead to molecular disruptions. The biological implications of this phenomenon were first emphasized by Feinendegen (1968) who reported that the biological effects of 125 1 labelled precursors of DNA were significantly in excess of the effect predicted on the basis of absorbed dose calculations. Many other radiobiological studies have shown that the Auger cascade may cause extensive damage to biological systems (Ahnstrom et al., 1970; Feinendegen et al., 1971; Krisch, 1972; Schmidt and Hot, 1973; Hoffer and Hughes, 1971) .
Feige discussed the implications of 125 1 decay in the thyroid gland and calculated the microscopic dose distribution within a thyroid cell. Greig, Feinendegen and their colleagues, independently, developed similar approaches to the cellular dosimetry of 125 1, in order to clarify biological and clinical findings (Gillespie et al., 1970; Greig et al., 1970; Ertl et al., 1970; Ertl and Feinendegen, 1970) .
The Auger Cascade
Auger electrons and characteristic x rays are emitted when vacancies in an inner electronic shell are filled. The primary vacancy in the electronic shell of the atom is usually produced by orbital electron capture, by in-47 :? 80 :;;: ternal conversion, or by photoelectric absorption of gamma or x-ray photons (Burhop and Asaad, 1972; Bambynek et al., 1972; Sevier, 1972; Bergstrom and Nordling, 1965) .
The probability of x-ray emission due to an initial vacancy, the fluorescent yield, WK, W L, is a function of the atomic charge Z, and the electronic shell involved. As can be seen from Figure D .l, the ejection of an Auger electron is the major relaxation process for excited states produced by a K-shell vacancy in low-Z elements. As Z increases beyond 32 (Ge), the predominant process is the emission of x rays, and the Auger effect becomes relatively unimportant for K shell vacancies. The deexcitation of an initial or secondary vacancy in the L shell is more complicated and consequently less well known in detail. The filling of M and higher shell vacancies involves Auger electrons, almost exclusively.
Some of the many vacancies created by the Auger cascade in the outermost shells of the now multiplycharged atom may be filled by electrons from other atoms in the same molecule. This intra-molecular charge transfer, which occurs during the final st.ages of the electronic readjustments, may easily disrupt molecular bonds. In gaseous compounds, multiply-charged molecular fragments have been observed after K-shell vacancies were produced by various means (Wexler, 1967; Snell, 1965; Carlson and White, 1964, 1966; Ore, 1967) . Molecular decomposition is also a possible con-sequence of the Auger cascade in the condensed phase, although some charge neutralization might already occur during the cascade; Halpern and Stocklin (1974) have pointed out that charge neutralization is a more likely process.
Dosimetry

General Considerations
For radionuclides decaying by electron capture, which localize in specific cells or cellular components, it is essential to deal separately with the two distinct types of low energy radiations involved. There are the fluorescent x ray photons which escape, and may thus be detected externally, and the Auger electrons, which have much shorter ranges in tissue for the same energies and are almost totally absorbed locally (Wrenn et al., 1973; Feige and Gavron, 1975) . The radionuclide 125 1 has been investigated more extensively than any of the other radionuclides decaying by electron capture. It decays to the 35.5 ke V excited level of 125 Te, which decays to its ground state by internal conversion or direct gamma emission. The electrons and photons resulting from this decay are shown in Table D 
In order to evaluate the absorbed fraction of these radiations in microscopic volumes, it is useful to consider the radii of volumes surrounding point sources in which 90% of the emitted energy is absorbed. Figure D radiations (Feige and Gavron, 1975; Martin and Blichert-Toft, 1970) . For 2-keV electrons, this range is about 0.1 µmin water, compared with 40 µm for a 2-keV x ray. They differ by a factor of 400. For 10-ke V radiations, the ratio of the ranges is over 2,000, i.e., 2 µm for electrons in water compared with 4.4 mm for 10-ke V x rays. The volume in which practically all the electron energy is deposited is many orders of magnitude smaller than that for x ray photons of comparable energy. I25J in the Thyroid Gland
The biological effectiveness of 125 I in animal and human thyroid glands has been compared with that of I31J. Experiments with rats have shown that 125 I may affect the system for production of the thyroid hormone, without damaging the system's response to the thyroid stimulating hormone TSH (Gross et al., 1968). These seemingly conflicting effects of 125 1 on various biological functions of the thyroid gland in mammals can be related to the inhomogeneous absorbed dose distribution from 1 25 1 within the thyroid follicle.
The thyroid gland of the rat consists of follicles, more or less rounded in shape varying from 40 µm to 70 µm in diameter. The shell of each follicle consists of a layer of closely packed living cells, a few µm thick. The nucleus occupies a significant portion of the cell volume. The space inside the follicle is filled with the colloid gel in which the iodine is stored (mainly in the form of thyroglobulin) (Feige et al., 1971; Gross et al., 1968) .
The absorbed dose rate distribution due to the Auger and conversion electrons of 12 51 across a typical rat thyroid follicle is shown in Figure D. 3. It is assumed that all the 125 1 is located in the colloid-cell interface, where the synthesis of thyroxine is completed, and the data illustrated in Figure D .3 show that the absorbed dose rate in the colloid is about 4 times higher than that in the cell nucleus, only a few µm away from that interface. The x -ray dose was neglected in this case (of a 10-mg thyroid gland).
Although the distribution of 1 3 1 1 is similarly nonuniform within the thyroid follicle, the absorbed dose is relatively uniformly distributed because the mean range of the beta particles of 131 1 exceeds, by far, the follicular diameter. 12 51 in Thyrotoxic Patients Gillespie et al. (1970) constructed a model of a "typical" human thyrotoxic thyroid follicle based on the histological studies of Heimann (1966) . They assumed a spherical colloid, 70 µm in diameter, with follicular cells 5 µm in diameter and 15 µm in length, placed end on against the colloid. Their nuclei are situated at 10 µm from the edge of the colloid compared to about 3 µm in the case of normal thyroid gland.
Assuming the colloid fraction to be 15% of the gland volume and that all the 125 1 is located in the colloid, the absorbed dose arising from electrons at the site of the nuclei of the follicular cells (10 µm distant from the colloid) is approximately one order of magnitude less than the dose at the cell/colloid interface. When 10% of the 125 1 is assumed to be located in the follicular cells themselves, and only 90% in the colloid, and if the absorbed fraction from photons is taken into account as well, the total absorbed dose to the nuclei is approximately 25% of the dose at the cell/colloid interface.
When the absorbed doses from equal administered activities of 131 Iand 125 1 are calculated, it is found that for the relatively short biological half-lives encountered in thyrotoxic patients, the absorbed dose derived for the colloid cell interface is approximately the same for both radionuclides. However, the mean absorbed dose to the cell nuclei in the case of 125 1 is a factor of 2 to 4 lower (Feige et al., 1971; Gillespie et al., 1970) . It should be noted that Bremner et al. of hyperthyroidism and conclude that 125 1 has no advantage over 1 3 1 1 for the routine management of hyperthyroidism. The Biological Effectiveness of 125 1 In the highly differentiated system of thyroid follicular structure 125 1 is concentrated mainly outside the cells in the colloid fluid. Only in those cases where the nsr is incorporated within structures of specific biological importance, such as in the DNA molecule inside the cell nucleus itself, will the biological consequences of molecular disruptions manifest themselves.
The effects of 1 2 5 1, incorporated into DNA molecules of proliferating mammalian cells, tissue cultures, as well as the bacteria and bacteriophages, have been studied in detail and compared to the effect observed by incorporating other radionuclides, mostly 3 H, 14 C or 3 2p_ Many authors report that the radiotoxicity of 125 1 is much higher than could be anticipated from the findings of other radionuclides in similar molecular posi-tions, especially with regard to cell killing effects, and that practically every 125 1 decay on a DNA strand causes a double-strand break (Ahnstrom et al., 1970; Feinendegen et al., 1971; Krisch, 1972; Schmidt and Hot, 1973; Hoffer and Hughes, 1971; Ertl et al., 1970; Roots et al., 1972; Krisch and Ley, 1974; Burki, 1974) . They tend to attribute the specific effects of 12 51 decaying within a labelled DNA molecule to molecular disruptions rather than to the dense ionizations produced by the electrons of the Auger cascade. Other explanations have also been suggested (Feige and Gavron, 1972) .
Hoffer and Hughes (1971) found that there was no shoulder in survival curves of 125 1-labelled leukemia cells; thus the biological effects of 125 1 resemble the effects produced by high-LET radiations, rather than electrons or x rays; and their findings are not inconsistent with the assumption of a LET-dependent quality factor for the low energy Auger electrons whose LET is about 10 keV µm-1 in tissue. Using LET calculations for electrons from 125 1 decay, Feige et al. (1971) derived a quality factor of about 3 for these Auger electrons.
However, as long as the enhanced effects produced by 125 1 can be attributed in part to other consequences of the Auger cascade, such as the large number of electrons (about 9 on the average) emitted isotropically during each decay, or to molecular disruptions (or transmutations), further experimental evidence should be critically analysed before using any LET-dependent quality factor for low energy electrons (Feige and Gavron, 1971, 1975; Gavron and Feige, 1972) . The ICRP amended its previous recommendations on this subject and suggested a quality factor of 1 for all electrons down to the lowest energies (from ICRP, 1969b ). An appropriate modifying factor, however, as proposed by Bond and Feinendegen (1966) could, perhaps, be useful in taking account of specific biological effects of radionuclides decaying mainly by electron capture.
Dosimetry of 3 H-and 14 C-Labelled Compounds
When we consider the dosimetry of internally deposited radionuclides which emit energetic (3 particles, it is often meaningful to calculate the mean dose throughout the tissue concerned. However, when the range of electrons is comparable to or less than the scale of inhomogeneity of radionuclide distributions, the absorbed dose becomes markedly non-uniform. Therefore, in materials labelled with 3 H and 14 C, for which the mean ranges of the (3 particles are, respectively, 1 µm and 40 µm, there will be considerable inhomogeneities of dose when the active deposits are separated by distances of the same order as the dimensions of cells: a fact which has caused considerable speculation concerning the importance of materials such as 3 Hand 14 C-labelled thymidine that specifically label the nuclei of actively dividing cells. The dosimetry of 3 H and 14 C uniformly labelling small volumes of tissues having dimensions comparable with the ranges of the (3 particles emitted by the radionuclides has been discussed by several authors, for example, Oliver (1960 ), Berry et al. (1966 and Bond and Feinendegen (1966) . Thus, Bond and Feinendegen have shown that about 20 per cent of the emitted {3-particle energy escapes from a sphere of density 1 g cm-3 and radius 4 µm which is uniformly labelled with tritium, a situation that might be considered typical of some cell nuclei labelled with the radionuclide. Calculations of absorbed dose for these low-energy {3-particle emitters in microscopically small volumes are, therefore, analogous to calculations of absorbed fraction for photon emitters in much larger volumes. By such methods, estimates can be made of the energy absorbed within nuclear or cellular volumes provided that the concentrations of activities within the volumes are known. These concentrations can be determined, by autoradiographic and other techniques, only when there is strict control of labelling, as is possible with experiments on cells cultured in vitro. Reported results from such experiments support the view that the absorbed energy resulting from ionization processes quantitatively accounts for effects observed, and any effects due to transmutation and recoil processes associated with the emission of the degen, 1966.) Problems of dosimetry are far more difficult for cells in vivo, mainly due to the fact that different tissues and cells are not homogeneous in respect of their sizes and rates of replication. The latter determines the degree of labelling and both factors affect the calculation of dose.
Considerations have thus far been restricted to variations in absorbed dose that are due to distributions of radionuclides that are non-uniform on the cellular or subcellular scale. A further complication is due to fluctuations that become important when the absorbed dose is small. The basic aspects of this phenomenon are discussed in ICRU Report 19 (ICRU, 1971) which contains a definition of the specific energy, z, that, like the absorbed dose, D, is expressed in terms of energy imparted per unit mass. However, z is the actual value of this quotient in volumes of given dimensions and it is subject to fluctuations about its mean value that is always equal to D. When the average number of events (appearance of charged particles and/or their secondaries) in the volumes under consideration is comparable to or less than one, the fluctuations become extreme and z ranges from zero to many times D.
These considerations apply for all internal or external irradiations. However, for a given absorbed dose, the fluctuations become more pronounced when the volumes under discussion become smaller and when the LET of the charged particles becomes larger. For example, according to Oliver and Lajtha (1960) , a fJ particle from 3 H having a mean range of about 1 µm can be considered to dissipate its energy in a sphere of 1 µm diameter, corresponding to a mean specific energy in such volumes of 1.7 Gy. Unless D is of the order of 10 Gy, fluctuations i1J 1 µm volumes will, therefore, be pronounced or even extreme.
Microdosimetric measurements that are, in essence, determinations of various distributions of z have been made utilizing low pressure proportional counters of the kind developed by Rossi (1962) and his collaborators.
Appendix D • • • 51
However, only a few of these measurements pertain to internal emitters. In addition to microdosimetric fluctuations, there are, of course, a considerable number of other variables that determine the biological effect of a given absorbed dose. These include the temporal distribution of absorbed energy and its relation to cell cycle time, oxygen tension, and the presence of many other substances that can alter the action of radiation. In addition, systemic and abscopal radiation responses may occur. A great deal more needs to be known about these, and perhaps other factors, before irradiation can be quantitatively expressed in terms other than absorbed dose or specific energy.
